🎉 Yesterday we launched online Mac4Me - an European doctoral network studying Macrophage Targets for Metastatic Treatment! We are investigating neuroblastoma, breast, and prostate cancers - three tumor types that share metastatic spread to brain, bone, and liver.
February 13, 2025 at 2:49 PM
🎉 Yesterday we launched online Mac4Me - an European doctoral network studying Macrophage Targets for Metastatic Treatment! We are investigating neuroblastoma, breast, and prostate cancers - three tumor types that share metastatic spread to brain, bone, and liver.
We, at the Mac4Me Horizon Europe MSCA (Marie Skłodowska-Curie Actions) Doctoral Network, embody this spirit by bringing together researchers, patients, and other stakeholders to address the challenges of metastatic neuroblastoma, prostate, and breast cancer. Learn more about our work: www.mac4me.eu
Home - Mac4me
Mac4me is dedicated to advancing metastatic neuroblastoma treatment through innovative research and immunotherapy solutions
www.mac4me.eu
September 24, 2025 at 9:06 AM
We, at the Mac4Me Horizon Europe MSCA (Marie Skłodowska-Curie Actions) Doctoral Network, embody this spirit by bringing together researchers, patients, and other stakeholders to address the challenges of metastatic neuroblastoma, prostate, and breast cancer. Learn more about our work: www.mac4me.eu
📢 The Mac4Me Doctoral Network is opening up some of our specialized online training modules (originally for our doctoral candidates) to the public! 🔬
We invite all interested researchers, students, and professionals to join us!
🗓️ Check the program and register here: mac4me.eu/online-semin...
We invite all interested researchers, students, and professionals to join us!
🗓️ Check the program and register here: mac4me.eu/online-semin...
Online seminar series November 2025 - Mac4me
The European doctoral network Mac4Me (Macrophage Targets for Metastatic Treatment) launched with a virtual meeting on 12 February 2025. Simultaneously, it also launched its digital and social media pr...
mac4me.eu
October 29, 2025 at 11:17 AM
📢 The Mac4Me Doctoral Network is opening up some of our specialized online training modules (originally for our doctoral candidates) to the public! 🔬
We invite all interested researchers, students, and professionals to join us!
🗓️ Check the program and register here: mac4me.eu/online-semin...
We invite all interested researchers, students, and professionals to join us!
🗓️ Check the program and register here: mac4me.eu/online-semin...
Mac4Me brings together 14 partners across Europe, training 18 Doctoral Candidates to transform cancer metastasis research. Learn more about our international consortium and approach at mac4me.eu
Home - Mac4me
Opening new doors
in cancer immunotherapy
A European doctoral network aiming to provide new treatment options for metastatic neuroblastoma, prostate and breast tumours Become one of our fello...
mac4me.eu
February 13, 2025 at 2:49 PM
Mac4Me brings together 14 partners across Europe, training 18 Doctoral Candidates to transform cancer metastasis research. Learn more about our international consortium and approach at mac4me.eu
The @mac4me.bsky.social project officially kicked off in Rotterdam on 25-26 June! It was great to connect with partners in person and meet our DC, Elena Montero Bragado.
🔗 Read the Full story: www.peptimatrix.com/post/mac4me-...
#Mac4Me #HorizonEurope #CancerResearch #3DCellCulture #MSCA
🔗 Read the Full story: www.peptimatrix.com/post/mac4me-...
#Mac4Me #HorizonEurope #CancerResearch #3DCellCulture #MSCA
Mac4Me Project Kicks off in Rotterdam
Mac4Me project kicks off with a meeting in Rotterdam and the first doctoral training session.
www.peptimatrix.com
July 8, 2025 at 11:19 AM
The @mac4me.bsky.social project officially kicked off in Rotterdam on 25-26 June! It was great to connect with partners in person and meet our DC, Elena Montero Bragado.
🔗 Read the Full story: www.peptimatrix.com/post/mac4me-...
#Mac4Me #HorizonEurope #CancerResearch #3DCellCulture #MSCA
🔗 Read the Full story: www.peptimatrix.com/post/mac4me-...
#Mac4Me #HorizonEurope #CancerResearch #3DCellCulture #MSCA
On European Patients' Rights Day, we remember that patients deserve effective treatment and clear information. Mac4Me's research aims to personalise immunotherapies for metastatic cancers, better predict treatment outcomes and keep people informed all the way through.
Learn more at mac4me.eu
Learn more at mac4me.eu
Home - Mac4me
Mac4me is dedicated to advancing metastatic neuroblastoma treatment through innovative research and immunotherapy solutions
mac4me.eu
April 18, 2025 at 10:46 AM
On European Patients' Rights Day, we remember that patients deserve effective treatment and clear information. Mac4Me's research aims to personalise immunotherapies for metastatic cancers, better predict treatment outcomes and keep people informed all the way through.
Learn more at mac4me.eu
Learn more at mac4me.eu
We are recruiting for a doctoral candidate for the Mac4Me network mac4me.eu formal advert soon but please forward to your networks. The project will focus on structural and functional analysis of GAGs in ageing and cancer. EU mobility rules apply
Home - Mac4me
Mac4me is dedicated to advancing metastatic neuroblastoma treatment through innovative research and immunotherapy solutions
mac4me.eu
February 12, 2025 at 9:29 AM
We are recruiting for a doctoral candidate for the Mac4Me network mac4me.eu formal advert soon but please forward to your networks. The project will focus on structural and functional analysis of GAGs in ageing and cancer. EU mobility rules apply
Today is #WorldCancerDay 2026. This year's #UnitedbyUnique initiative calls for "people-centered care"—a shift from treating just the disease to treating the unique person behind it.
Mac4Me translates this vision into research for metastatic neuroblastoma, prostate, and breast cancers. 🧬
Mac4Me translates this vision into research for metastatic neuroblastoma, prostate, and breast cancers. 🧬
February 4, 2026 at 9:33 AM
Today is #WorldCancerDay 2026. This year's #UnitedbyUnique initiative calls for "people-centered care"—a shift from treating just the disease to treating the unique person behind it.
Mac4Me translates this vision into research for metastatic neuroblastoma, prostate, and breast cancers. 🧬
Mac4Me translates this vision into research for metastatic neuroblastoma, prostate, and breast cancers. 🧬
Mac4Me is a European doctoral network aiming to provide new treatment options for metastatic neuroblastoma, prostate and breast tumours.
Meet Sidney van der Zande, one of the 18 @mac4me.bsky.social doctoral candidates, supervised by Teijo Pellinen at FIMM:
📽️ www.youtube.com/watch?v=ficq...
Meet Sidney van der Zande, one of the 18 @mac4me.bsky.social doctoral candidates, supervised by Teijo Pellinen at FIMM:
📽️ www.youtube.com/watch?v=ficq...
Sidney van der Zande
YouTube video by Mac4Me
www.youtube.com
January 22, 2026 at 2:15 PM
Mac4Me is a European doctoral network aiming to provide new treatment options for metastatic neuroblastoma, prostate and breast tumours.
Meet Sidney van der Zande, one of the 18 @mac4me.bsky.social doctoral candidates, supervised by Teijo Pellinen at FIMM:
📽️ www.youtube.com/watch?v=ficq...
Meet Sidney van der Zande, one of the 18 @mac4me.bsky.social doctoral candidates, supervised by Teijo Pellinen at FIMM:
📽️ www.youtube.com/watch?v=ficq...
At the Mac4Me consortium, we bring together leading European institutions to foster innovation and train the next generation of cancer researchers.
Today, we are opening our lab doors to show the daily work behind research.
Today, we are opening our lab doors to show the daily work behind research.
September 24, 2026 at 1:20 PM
At the Mac4Me consortium, we bring together leading European institutions to foster innovation and train the next generation of cancer researchers.
Today, we are opening our lab doors to show the daily work behind research.
Today, we are opening our lab doors to show the daily work behind research.
As part of Mac4Me @mac4me.bsky.social, we study health communication and public views on metastatic cancer. Our PhD student Aina Amat examines how patients/public understand advances and how to close knowledge gaps. #WorldCancerResearchDay
Today, September 24th, is #WorldCancerResearchDay. It is a yearly momentum to raise
awareness and commitment for cancer research. This day also serves as a reminder that
progress depends on collaboration.
awareness and commitment for cancer research. This day also serves as a reminder that
progress depends on collaboration.
September 25, 2025 at 10:28 AM
As part of Mac4Me @mac4me.bsky.social, we study health communication and public views on metastatic cancer. Our PhD student Aina Amat examines how patients/public understand advances and how to close knowledge gaps. #WorldCancerResearchDay
While prevention and early detection are vital, the Mac4Me Doctoral Network focuses on
researching the critical, complex challenge that follows: metastasis 🔬.
#InternationalDayAgainstBreastCancer #BreastCancerResearch #Mac4Me
researching the critical, complex challenge that follows: metastasis 🔬.
#InternationalDayAgainstBreastCancer #BreastCancerResearch #Mac4Me
October 19, 2025 at 4:14 PM
While prevention and early detection are vital, the Mac4Me Doctoral Network focuses on
researching the critical, complex challenge that follows: metastasis 🔬.
#InternationalDayAgainstBreastCancer #BreastCancerResearch #Mac4Me
researching the critical, complex challenge that follows: metastasis 🔬.
#InternationalDayAgainstBreastCancer #BreastCancerResearch #Mac4Me
RCSI is delighted to be part of the #Mac4Me European doctoral network, advancing vital research into cancer metastasis.
Through our involvement led by Dr Olga Piskareva, we look forward to contributing our expertise and collaborating with our partners to drive meaningful progress.
#RCSIdiscover
Through our involvement led by Dr Olga Piskareva, we look forward to contributing our expertise and collaborating with our partners to drive meaningful progress.
#RCSIdiscover
🎉 Yesterday we launched online Mac4Me - an European doctoral network studying Macrophage Targets for Metastatic Treatment! We are investigating neuroblastoma, breast, and prostate cancers - three tumor types that share metastatic spread to brain, bone, and liver.
February 14, 2025 at 1:57 PM
RCSI is delighted to be part of the #Mac4Me European doctoral network, advancing vital research into cancer metastasis.
Through our involvement led by Dr Olga Piskareva, we look forward to contributing our expertise and collaborating with our partners to drive meaningful progress.
#RCSIdiscover
Through our involvement led by Dr Olga Piskareva, we look forward to contributing our expertise and collaborating with our partners to drive meaningful progress.
#RCSIdiscover
The @marubin1.bsky.social is part of Mac4Me, a European doctoral network aiming to develop new treatment options for metastatic neuroblastoma, prostate, and breast cancers.
🚀 The first Mac4Me Newsletter is here!
Catch up on our latest research updates in metastatic neuroblastoma, prostate, and breast cancer.
📖 Read the first issue: mac4me.eu/newsletter-a...
📩 Subscribe: mac4me.us22.list-manage.com/subscribe?u=...
Catch up on our latest research updates in metastatic neuroblastoma, prostate, and breast cancer.
📖 Read the first issue: mac4me.eu/newsletter-a...
📩 Subscribe: mac4me.us22.list-manage.com/subscribe?u=...
December 19, 2025 at 3:21 PM
The @marubin1.bsky.social is part of Mac4Me, a European doctoral network aiming to develop new treatment options for metastatic neuroblastoma, prostate, and breast cancers.
🌍 Led by 14 core partners and supported by 11 associated partners, this project brings together experts from basic science, biomedical engineering, social sciences, computational biology, and other disciplines.
To learn more about our mission, visit our website: 🌐🔗 mac4me.eu
To learn more about our mission, visit our website: 🌐🔗 mac4me.eu
Home - Mac4me
Mac4me is dedicated to advancing metastatic neuroblastoma treatment through innovative research and immunotherapy solutions
mac4me.eu
July 8, 2025 at 2:52 PM
🌍 Led by 14 core partners and supported by 11 associated partners, this project brings together experts from basic science, biomedical engineering, social sciences, computational biology, and other disciplines.
To learn more about our mission, visit our website: 🌐🔗 mac4me.eu
To learn more about our mission, visit our website: 🌐🔗 mac4me.eu
Prof. Dr. Andreas Weigert erforscht die Immunologie der Entzündung
Der Inhaber der gleichnamigen Stiftungsprofessur ist am Doktorandennetzwerk Mac4Me beteiligt....
weiterlesen
Der Inhaber der gleichnamigen Stiftungsprofessur ist am Doktorandennetzwerk Mac4Me beteiligt....
weiterlesen
August 7, 2025 at 11:32 AM
Prof. Dr. Andreas Weigert erforscht die Immunologie der Entzündung
Der Inhaber der gleichnamigen Stiftungsprofessur ist am Doktorandennetzwerk Mac4Me beteiligt....
weiterlesen
Der Inhaber der gleichnamigen Stiftungsprofessur ist am Doktorandennetzwerk Mac4Me beteiligt....
weiterlesen
🎊 The Mac4Me Doctoral Network officially kicked off two weeks ago (25-26 June)! 🎉 Our core partners gathered to set the stage for four years of research. We're excited for what's ahead!
July 8, 2025 at 2:52 PM
🎊 The Mac4Me Doctoral Network officially kicked off two weeks ago (25-26 June)! 🎉 Our core partners gathered to set the stage for four years of research. We're excited for what's ahead!
🎤Gema moderó la sesión “Comunicación científica y salud” y presentó “Perfiles profesionales de la comunicación científica en España”.
💡 Carolina presentó el proyecto FRONTIERS.
🧬 Aina su investigación predoctoral sobre percepción pública y comunicación del cáncer metastásico (proyecto Mac4Me). 3/4
💡 Carolina presentó el proyecto FRONTIERS.
🧬 Aina su investigación predoctoral sobre percepción pública y comunicación del cáncer metastásico (proyecto Mac4Me). 3/4
November 5, 2025 at 10:48 AM
🎤Gema moderó la sesión “Comunicación científica y salud” y presentó “Perfiles profesionales de la comunicación científica en España”.
💡 Carolina presentó el proyecto FRONTIERS.
🧬 Aina su investigación predoctoral sobre percepción pública y comunicación del cáncer metastásico (proyecto Mac4Me). 3/4
💡 Carolina presentó el proyecto FRONTIERS.
🧬 Aina su investigación predoctoral sobre percepción pública y comunicación del cáncer metastásico (proyecto Mac4Me). 3/4
🎗️ 15th of February is #InternationalChildhoodCancerDay.
At #Mac4Me, our ultimate goal is to improve treatment options for metastatic #Neuroblastoma. We research:
🔹 3D printing miniature brain models to stop tumor survival.
🔹 Chips that mimic blood flow to block cancer from spreading.
At #Mac4Me, our ultimate goal is to improve treatment options for metastatic #Neuroblastoma. We research:
🔹 3D printing miniature brain models to stop tumor survival.
🔹 Chips that mimic blood flow to block cancer from spreading.
February 15, 2026 at 11:18 PM
🎗️ 15th of February is #InternationalChildhoodCancerDay.
At #Mac4Me, our ultimate goal is to improve treatment options for metastatic #Neuroblastoma. We research:
🔹 3D printing miniature brain models to stop tumor survival.
🔹 Chips that mimic blood flow to block cancer from spreading.
At #Mac4Me, our ultimate goal is to improve treatment options for metastatic #Neuroblastoma. We research:
🔹 3D printing miniature brain models to stop tumor survival.
🔹 Chips that mimic blood flow to block cancer from spreading.
🌟 Exciting PhD opportunity 🌟 Join PeptiMatrix & the Mac4Me Network to develop cutting-edge 3D liver models for studying cancer metastasis. 🌍🔬
📍 Based in Nottingham
🤝 Collaborate across Europe
💡 Shape the future of cancer treatment!
Apply here now: bit.ly/3PljRZz
📍 Based in Nottingham
🤝 Collaborate across Europe
💡 Shape the future of cancer treatment!
Apply here now: bit.ly/3PljRZz
January 3, 2025 at 12:52 PM
🌟 Exciting PhD opportunity 🌟 Join PeptiMatrix & the Mac4Me Network to develop cutting-edge 3D liver models for studying cancer metastasis. 🌍🔬
📍 Based in Nottingham
🤝 Collaborate across Europe
💡 Shape the future of cancer treatment!
Apply here now: bit.ly/3PljRZz
📍 Based in Nottingham
🤝 Collaborate across Europe
💡 Shape the future of cancer treatment!
Apply here now: bit.ly/3PljRZz
📚 Entre los hitos: avances en FRONTIERS, Mac4Me, PERFILES, REPROGENÓMICA y Proyecto Quiral; nuevas publicaciones, presencia en PCST, RedPOP y Campus Gutenberg; talleres, pódcasts y la promoción 31 del Máster en Comunicación Científica, Médica y Ambiental. 2/3
December 23, 2025 at 2:11 PM
📚 Entre los hitos: avances en FRONTIERS, Mac4Me, PERFILES, REPROGENÓMICA y Proyecto Quiral; nuevas publicaciones, presencia en PCST, RedPOP y Campus Gutenberg; talleres, pódcasts y la promoción 31 del Máster en Comunicación Científica, Médica y Ambiental. 2/3
Mac4Me, a Horizon Europe MSCA Doctoral Network where FIMM is a partner, has kicked off with a meeting and the first training session! By examining how tumour cells invade healthy tissues, @mac4me.bluesky.social develops new strategies for understanding and treating metastatic disease: mac4me.eu
July 16, 2025 at 11:17 AM
Mac4Me, a Horizon Europe MSCA Doctoral Network where FIMM is a partner, has kicked off with a meeting and the first training session! By examining how tumour cells invade healthy tissues, @mac4me.bluesky.social develops new strategies for understanding and treating metastatic disease: mac4me.eu
Hi, Mac4Me! Congrats on the launch! I'm Sofía, an applicant for the SciComm position at @ccsupf.bsky.social. I applied last Dec but haven't heard back via mail, so I'm checking in here to see if the process is still ongoing. I’m very excited about this opportunity and don’t want to give up hope yet!
March 5, 2025 at 6:06 PM
Hi, Mac4Me! Congrats on the launch! I'm Sofía, an applicant for the SciComm position at @ccsupf.bsky.social. I applied last Dec but haven't heard back via mail, so I'm checking in here to see if the process is still ongoing. I’m very excited about this opportunity and don’t want to give up hope yet!
🥂 Happy New Year from Mac4Me!
We’re celebrating the power of international collaboration in the fight against metastatic cancer. Looking forward to a year of bold questions and shared milestones.
Here’s to a year of discovery, collaboration, and scientific progress!! 🚀
We’re celebrating the power of international collaboration in the fight against metastatic cancer. Looking forward to a year of bold questions and shared milestones.
Here’s to a year of discovery, collaboration, and scientific progress!! 🚀
January 2, 2026 at 5:42 PM
🥂 Happy New Year from Mac4Me!
We’re celebrating the power of international collaboration in the fight against metastatic cancer. Looking forward to a year of bold questions and shared milestones.
Here’s to a year of discovery, collaboration, and scientific progress!! 🚀
We’re celebrating the power of international collaboration in the fight against metastatic cancer. Looking forward to a year of bold questions and shared milestones.
Here’s to a year of discovery, collaboration, and scientific progress!! 🚀
🚀 The first Mac4Me Newsletter is here!
Catch up on our latest research updates in metastatic neuroblastoma, prostate, and breast cancer.
📖 Read the first issue: mac4me.eu/newsletter-a...
📩 Subscribe: mac4me.us22.list-manage.com/subscribe?u=...
Catch up on our latest research updates in metastatic neuroblastoma, prostate, and breast cancer.
📖 Read the first issue: mac4me.eu/newsletter-a...
📩 Subscribe: mac4me.us22.list-manage.com/subscribe?u=...
December 19, 2025 at 11:05 AM
🚀 The first Mac4Me Newsletter is here!
Catch up on our latest research updates in metastatic neuroblastoma, prostate, and breast cancer.
📖 Read the first issue: mac4me.eu/newsletter-a...
📩 Subscribe: mac4me.us22.list-manage.com/subscribe?u=...
Catch up on our latest research updates in metastatic neuroblastoma, prostate, and breast cancer.
📖 Read the first issue: mac4me.eu/newsletter-a...
📩 Subscribe: mac4me.us22.list-manage.com/subscribe?u=...